InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Clark William D, 首席执行官. Officer active across 2 companies, notably Genocea Biosciences, INC.. Cumulatively, 5 reports have been logged. Split: 1 buy · 3 sells. Total volume traded: €10k. History available since 15 March 2022. The latest transaction was filed on 10 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Clark William D is Président et directeur général. He is also listed as President and CEO at Genocea Biosciences, INC. and as Director at iBio, Inc. He has 5 filings in total, and across the 5 recent filings available, the summed amounts are EUR 4855 in buys and EUR 4693 in sells, between 2022-03-17 and 2025-01-13. The modal transaction nature is Cession.